Once-Weekly Oral GLP-1 Peptide GZC8072 Enters First-in-Human Study

Gan & Lee says the first participant has been dosed in a Phase 1 study of its investigational onceweekly oral GLP1 receptor agonist.

For research use only. Not for human consumption.